These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous subacute stent thrombosis of two drug-eluting stents in the left anterior descending and the circumflex coronary arteries. Case report and review of the literature. Movahed MR; Vu J; Ahsan C J Invasive Cardiol; 2006 Jul; 18(7):E198-202. PubMed ID: 16816448 [TBL] [Abstract][Full Text] [Related]
8. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related]
9. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W; Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Qasim A; Cosgrave J; Latib A; Colombo A Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358 [TBL] [Abstract][Full Text] [Related]
11. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease. Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030 [TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. Ren X; Trilesskaya M; Kwan DM; Nguyen K; Shaw RE; Hui PY Am J Cardiol; 2009 Jul; 104(2):216-22. PubMed ID: 19576350 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ; Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057 [TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry. Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065 [TBL] [Abstract][Full Text] [Related]